• Welcome to Specialised Therapeutics
  • SE Asia (HQ)

    +65 3158 9940

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

November 2017 - ST – Puma Biotechnology Partnership

ST partners with US-based Puma Biotechnology, acquiring exclusive rights to market NERLYNX® (neratinib) in Australia, NZ and South-East Asia